Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 2.043
Filtrar
1.
Palmas; [Secretaria de Estado da Saúde]; 20200000. 22 p.
Monografia em Português | LILACS, Coleciona SUS, CONASS, SES-TO | ID: biblio-1120798

RESUMO

Regimento para estabelecer normas, competências e procedimentos da Comissão Permanente de Integração Ensino-Serviço do Estado do Tocantins - CIES Estadual/CIB-TO, que é uma instância intersetorial e interinstitucional permanente que participa da formulação, condução, monitoramento e avaliação da Política de Educação Permanente em Saúde ­ EPS e atende o disposto no artigo 14 da Lei 8.080/1990, regulamentada pelo Decreto Presidencial N°. 7.508, de 28 de junho de 2011, e a Norma Operacional Básica de Recursos Humanos em Saúde (NOB/RH-SUS).


Rules to establish rules, competences and procedures of the Permanent Commission for Teaching-Service Integration of the State of Tocantins - State CIES / CIB-TO, which is a permanent intersectoral and interinstitutional body that participates in the formulation, conduction, monitoring and evaluation of the Education Policy Permanent in Health - EPS and meets the provisions of article 14 of Law 8.080 / 1990, regulated by Presidential Decree N °. 7,508, of June 28, 2011, and the Basic Operational Standard for Human Resources in Health (NOB / RH-SUS).


Normas para establecer normas, competencias y procedimientos de la Comisión Permanente de Integración Docente-Servicio del Estado de Tocantins - Estatal CIES / CIB-TO, que es un órgano permanente intersectorial e interinstitucional que participa en la formulación, conducción, seguimiento y evaluación de la Política Educativa. Permanente en Salud - EPS y cumple con lo dispuesto en el artículo 14 de la Ley 8.080 / 1990, reglamentado por Decreto Presidencial N °. 7,508, del 28 de junio de 2011, y la Norma Básica Operativa de Recursos Humanos en Salud (NOB / RH-SUS).


Assuntos
Diretrizes para o Planejamento em Saúde , Organizações/normas , Colaboração Intersetorial , Guias como Assunto/normas , Regulamentação Governamental , Educação Continuada/organização & administração , Direção e Governança do Setor de Saúde/normas , Conselho Diretor/normas
2.
Lancet Oncol ; 21(9): e444-e451, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32888473

RESUMO

Population-based cancer registries (PBCRs) generate measures of cancer incidence and survival that are essential for cancer surveillance, research, and cancer control strategies. In 2014, the Toronto Paediatric Cancer Stage Guidelines were developed to standardise how PBCRs collect data on the stage at diagnosis for childhood cancer cases. These guidelines have been implemented in multiple jurisdictions worldwide to facilitate international comparative studies of incidence and outcome. Robust stratification by risk also requires data on key non-stage prognosticators (NSPs). Key experts and stakeholders used a modified Delphi approach to establish principles guiding paediatric cancer NSP data collection. With the use of these principles, recommendations were made on which NSPs should be collected for the major malignancies in children. The 2014 Toronto Stage Guidelines were also reviewed and updated where necessary. Wide adoption of the resultant Paediatric NSP Guidelines and updated Toronto Stage Guidelines will enhance the harmonisation and use of childhood cancer data provided by PBCRs.


Assuntos
Guias como Assunto/normas , Neoplasias/terapia , Pediatria/tendências , Prognóstico , Criança , Assistência à Saúde , Humanos , Estadiamento de Neoplasias , Neoplasias/epidemiologia , Sistema de Registros
3.
Nurs Clin North Am ; 55(3): 295-305, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32762851

RESUMO

Evidence-based guidelines have improved diagnosis and treatment of sexually transmitted infections (STI). Social stigma remains a barrier to STI testing and is associated with underutilization of prevention services. Alternatives for STI testing (eg, in-home testing) are convenient. However, some individuals decline follow-up treatment in fear of unintentional disclosure of their diagnosis. This article reviews STI treatment guidelines and examines the impact of stigma and ethical issues on testing, adherence, partner notification, and transmission rates. An understanding of STI-associated ethical issues and controversies is an important step toward eliminating stigma and reducing STI prevalence and morbidity.


Assuntos
Guias como Assunto/normas , Aceitação pelo Paciente de Cuidados de Saúde , Doenças Sexualmente Transmissíveis , Estigma Social , Centers for Disease Control and Prevention, U.S./normas , Infecções por HIV/terapia , Infecções por HIV/transmissão , Humanos , Doenças Sexualmente Transmissíveis/classificação , Doenças Sexualmente Transmissíveis/terapia , Estados Unidos
4.
Nurs Clin North Am ; 55(3): 307-323, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32762852

RESUMO

Sexually transmitted infections (STIs) are a prevalent global health care problem. Incidence rates are rising yearly. STI incidence is highest for adolescents and young adults ages 15 to 24, who are diagnosed with half of all new STIs. Chlamydia trachomatis and Neisseria gonorrhea are common STIs caused by bacteria. Treatment guidelines change frequently as a result of antimicrobial resistance and public health trends. It is important for primary care providers to remain up to date with new guidelines. This article provides updates on pharmacologic treatment as well as patient education and follow-up specific to the primary care setting.


Assuntos
Guias como Assunto/normas , Doenças Sexualmente Transmissíveis/tratamento farmacológico , Doenças Sexualmente Transmissíveis/epidemiologia , Adolescente , Adulto , Resistência Microbiana a Medicamentos , Saúde Global , Humanos , Incidência , Doenças Sexualmente Transmissíveis/classificação , Estados Unidos/epidemiologia
5.
Nurs Clin North Am ; 55(3): 347-359, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32762855

RESUMO

Hepatitis C virus (HCV) is a common infectious disease affecting people worldwide. In the past 10 years, the incidence of HCV has steadily increased in the United States. With the advent of new direct-acting antiviral medications, the treatment of HCV has become important and can cure the infection.


Assuntos
Antivirais , Guias como Assunto/normas , Hepacivirus/isolamento & purificação , Hepatite C/tratamento farmacológico , Hepatite C/epidemiologia , Antivirais/farmacologia , Antivirais/uso terapêutico , Genótipo , Hepacivirus/classificação , Hepatite C/fisiopatologia , Humanos , Incidência , Fatores de Risco , Estados Unidos/epidemiologia
6.
Nurs Clin North Am ; 55(3): 361-377, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32762856

RESUMO

Despite the near-eradication of syphilis in the United States in the late 1990s, new infections have surged over the past 20 years. Dubbed, "the great imitator," syphilis infections often can be misdiagnosed and resultantly untreated. This leads to people inadvertently infecting others. This article reviews the history of syphilis, including the unethical studies undertaken in the past; current epidemiology; treatment guidelines; and strategies to reduce new infections.


Assuntos
Guias como Assunto/normas , Disparidades em Assistência à Saúde/estatística & dados numéricos , Sífilis/epidemiologia , Sífilis/história , Grupos Étnicos/estatística & dados numéricos , Disparidades em Assistência à Saúde/história , História do Século XIX , História do Século XX , História do Século XXI , Homossexualidade Masculina/psicologia , Humanos , Masculino , Profissionais de Enfermagem , Reação em Cadeia da Polimerase , Prevalência , Sífilis/diagnóstico , Pessoas Transgênero/psicologia , Estados Unidos/epidemiologia
8.
J Stud Alcohol Drugs ; 81(2): 262-272, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32359057

RESUMO

OBJECTIVE: Alcohol labels are one strategy for communicating health information to consumers. This study tested the extent to which consumers recalled alcohol labels with national drinking guidelines and examined the impact of labels on awareness and knowledge of the guidelines. METHOD: A quasi-experimental study was conducted in two jurisdictions in northern Canada examining the impact of labels on the following outcomes: unprompted and prompted recall of the drinking guideline label message, awareness of the drinking guidelines, and knowledge of the daily and weekly recommended drink limits. The intervention site applied labels with national drinking guidelines, a cancer warning, and standard drink information to alcohol containers in its liquor store, whereas the comparison site did not apply these labels. In total, 2,049 cohort participants in both sites were recruited to complete surveys before and at two time points after the intervention. Changes in outcomes were examined using generalized estimating equations. RESULTS: After the intervention, unprompted and prompted recall of the drinking guideline label message increased more in the intervention versus comparison site (adjusted odds ratio [AOR] = 10.8, 95% CI [0.9, 127.6]; AOR = 7.0, 95% CI [3.3, 14.9], respectively). Awareness of the drinking guidelines increased 2.9 times more in the intervention versus comparison site (AOR = 2.9, 95% CI [2.0, 4.3]). In addition, knowledge of the daily and weekly drink limits increased 1.5 and 1.4 times more in the intervention versus comparison site, respectively (daily: AOR = 1.5, 95% CI [1.0, 2.1]; weekly: AOR = 1.4, 95% CI [1.0, 2.0]). CONCLUSIONS: Enhanced alcohol labels get noticed and may be an effective population-level strategy for increasing awareness and knowledge of national drinking guidelines.


Assuntos
Consumo de Bebidas Alcoólicas/efeitos adversos , Consumo de Bebidas Alcoólicas/prevenção & controle , Bebidas Alcoólicas/efeitos adversos , Conhecimentos, Atitudes e Prática em Saúde , Neoplasias/prevenção & controle , Rotulagem de Produtos/normas , Adulto , Consumo de Bebidas Alcoólicas/epidemiologia , Conscientização/fisiologia , Estudos de Coortes , Feminino , Guias como Assunto/normas , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Estudos Prospectivos , Inquéritos e Questionários , Yukon/epidemiologia
12.
BMC Public Health ; 20(1): 347, 2020 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-32183754

RESUMO

BACKGROUND: We compared the prevalence, awareness, treatment, and control of hypertension in Iran based on two hypertension guidelines; the 2017 ACC/AHA -with an aggressive blood pressure target of 130/80 mmHg- and the commonly used JNC8 guideline cut-off of 140/90 mmHg. We shed light on the implications of the 2017 ACC/AHA for population subgroups and high-risk individuals who were eligible for non-pharmacologic and pharmacologic therapies. METHODS: Data was obtained from the Iran national STEPS 2016 study. Participants included 27,738 adults aged ≥25 years as a representative sample of Iranians. Regression models of survey design were used to examine the determinants of prevalence, awareness, treatment, and control of hypertension. RESULTS: The prevalence of hypertension based on JNC8 was 29.9% (95% CI: 29.2-30.6), which soared to 53.7% (52.9-54.4) based on the 2017 ACC/AHA. The percentage of awareness, treatment, and control were 59.2% (58.0-60.3), 80.2% (78.9-81.4), and 39.1% (37.4-40.7) based on JNC8, which dropped to 37.1% (36.2-38.0), 71.3% (69.9-72.7), and 19.6% (18.3-21.0), respectively, by applying the 2017 ACC/AHA. Based on the new guideline, adults aged 25-34 years had the largest increase in prevalence (from 7.3 to 30.7%). They also had the lowest awareness and treatment rate, contrary to the highest control rate (36.5%) between age groups. Compared with JNC8, based on the 2017 ACC/AHA, 24, 15, 17, and 11% more individuals with dyslipidaemia, high triglycerides, diabetes, and cardiovascular disease events, respectively, fell into the hypertensive category. Yet, based on the 2017 ACC/AHA, 68.2% of individuals falling into the hypertensive category were eligible for receiving pharmacologic therapy (versus 95.7% in JNC8). LDL cholesterol< 130 mg/dL, sufficient physical activity (Metabolic Equivalents≥600/week), and Body Mass Index were found to change blood pressure by - 3.56(- 4.38, - 2.74), - 2.04(- 2.58, - 1.50), and 0.48(0.42, 0.53) mmHg, respectively. CONCLUSIONS: Switching from JNC8 to 2017 ACC/AHA sharply increased the prevalence and drastically decreased the awareness, treatment, and control in Iran. Based on the 2017 ACC/AHA, more young adults and those with chronic comorbidities fell into the hypertensive category; these individuals might benefit from earlier interventions such as lifestyle modifications. The low control rate among individuals receiving treatment warrants a critical review of hypertension services.


Assuntos
Guias como Assunto/normas , Hipertensão/terapia , Avaliação de Resultados em Cuidados de Saúde/normas , Cobertura Universal do Seguro de Saúde/estatística & dados numéricos , Adulto , Idoso , Pressão Sanguínea , Determinação da Pressão Arterial , Feminino , Humanos , Hipertensão/epidemiologia , Irã (Geográfico)/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevalência , Padrões de Referência , Adulto Jovem
13.
Zhonghua Gan Zang Bing Za Zhi ; 28(2): 129-132, 2020 Feb 20.
Artigo em Chinês | MEDLINE | ID: mdl-32164062

RESUMO

The key points from the updated guideline of prevention and treatment for hepatitis C (2019 version) is compared with the previous hepatitis C guideline. A new terminology and the World Health Organization's goal of eliminating viral hepatitis as a public-health threat by 2030 are stressed. In the prevention section, the screening for hepatitis C virus infection in high-risk population is the primary means of prevention, emphasizing that treatment, is prevention. In the aspect of treatment, pangenotypic interferon-free scheme are initial recommendations. In addition, it also introduces our country independent research and development on direct-acting antiviral agents, and antiviral therapy schedule for many special populations, including decompensated liver cirrhosis, chronic kidney disease, children and adolescents combined with chronic kidney injury, HBV infection-before and after liver transplantation, treatment failure, and acute hepatitis C. A simplified on-treatment monitoring schedule, especially genotype 3 prevalent in Southwest part of our country is introduced.


Assuntos
Antivirais/uso terapêutico , Guias como Assunto/normas , Hepatite C/tratamento farmacológico , Hepatite C/prevenção & controle , Interferons/uso terapêutico , Guias de Prática Clínica como Assunto , Adolescente , Criança , Medicina Baseada em Evidências , Hepacivirus/efeitos dos fármacos , Hepacivirus/isolamento & purificação , Hepatite C/diagnóstico , Humanos , Cirrose Hepática , Prevenção Primária/métodos , Resultado do Tratamento
14.
Infection ; 48(2): 155-163, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: covidwho-1221

RESUMO

There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days.


Assuntos
Betacoronavirus/classificação , Betacoronavirus/fisiologia , Infecções por Coronavirus/epidemiologia , Pandemias/estatística & dados numéricos , Pneumonia Viral/epidemiologia , Animais , Infecções por Coronavirus/patologia , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/transmissão , Gerenciamento Clínico , Guias como Assunto/normas , Humanos , Pandemias/prevenção & controle , Pneumonia Viral/patologia , Pneumonia Viral/prevenção & controle , Pneumonia Viral/transmissão , Organização Mundial da Saúde
15.
Nervenarzt ; 91(3): 193-206, 2020 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-32076760

RESUMO

Since the first publication of the guideline in 2012, which included critically reviewed evidence up to 2010, several hundred articles with new evidence were published and some topics of the clinical consensus needed to be reconsidered. Therefore, it was urgently necessary to revise the guideline to bring them up to date. In this article important revisions and updates are presented and the chances and limitations of the development of the guidelines and their implementation are discussed.


Assuntos
Transtorno Bipolar , Guias como Assunto , Transtorno Bipolar/diagnóstico , Transtorno Bipolar/terapia , Alemanha , Guias como Assunto/normas , Humanos
16.
Int J Med Inform ; 136: 104038, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32078979

RESUMO

BACKGROUND: The Clinical Practice Research Datalink (CPRD) GOLD is an extremely influential U.K. primary care dataset for epidemiological research having a number of published papers based on its data much bigger than any other U.K. primary care dataset. The Office for National Statistics (ONS) death data for England can be linked to GOLD at the patient level and are considered the gold standard on mortality. GOLD, which also holds death data, has been recently assessed against ONS linked dataset and the accuracy of its dates of death has been deemed sufficient for the majority of observational studies. However, there is a lack of guidance on how to manage the challenges existing when ONS mortality and GOLD datasets are linked, including linkage coverage period, linkage correctness likelihood, linkage regional limitations and data discrepancy. OBJECTIVES: Provide reconciling guidelines on how to make maximum and at the same time trustworthy use of mortality information coming from both GOLD and ONS linked datasets with the aim of improving the quality, reproducibility, transparency and comparison of clinical research. METHOD AND RESULTS: We have developed recommendations on how to manage mortality data coming from both GOLD and linked ONS, taking into account linkage coverage period, linkage correctness likelihood, linkage regional limitations and data discrepancies between these two datasets. We have also implemented these guidelines in an SQL algorithm for researchers to use. CONCLUSION: We have provided detailed guidelines on the reconciliation of mortality data between GOLD and ONS linked death datasets, taking into account both their strengths and limitations. The consistent application of these guidelines made practical by an SQL algorithm, has the potential to improve clinical research quality, reproducibility, transparency and comparison.


Assuntos
Algoritmos , Coleta de Dados/normas , Registros Eletrônicos de Saúde/estatística & dados numéricos , Guias como Assunto/normas , Registro Médico Coordenado/métodos , Mortalidade/tendências , Atenção Primária à Saúde/estatística & dados numéricos , Bases de Dados Factuais , Inglaterra , Humanos , Estudos Observacionais como Assunto , Reprodutibilidade dos Testes
17.
Plast Reconstr Surg ; 145(3): 803-812, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32097329

RESUMO

BACKGROUND: Despite the multiple benefits of gender-affirming surgery for treatment of gender dysphoria, research shows that barriers to care still exist. Third-party payers play a pivotal role in enabling access to transition-related care. The authors assessed insurance coverage of genital reconstructive ("bottom") surgery and evaluated the differences between policy criteria and international standards of care. METHODS: A cross-sectional analysis of insurance policies for coverage of bottom surgery was conducted. Insurance companies were selected based on their state enrollment data and market share. A Web-based search and telephone interviews were performed to identify the policies and coverage status. Medical necessity criteria were abstracted from publicly available policies. RESULTS: Fifty-seven insurers met inclusion criteria. Almost one in 10 providers did not hold a favorable policy for bottom surgery. Of the 52 insurers who provided coverage, 17 percent held criteria that matched international recommendations. No single criterion was universally required by insurers. Minimum age and definition of gender dysphoria were the requirements with most variation across policies. Almost one in five insurers used proof of legal name change as a coverage requirement. Ten percent would provide coverage for fertility preservation, while 17 percent would cover reversal of the procedure. CONCLUSIONS: Despite the medical necessity, legislative mandates, and economic benefits, global provision of gender-affirming genital surgery is not in place. Furthermore, there is variable adherence to international standards of care. Use of surplus criteria, such as legal name change, may act as an additional barrier to care even when insurance coverage is provided.


Assuntos
Disforia de Gênero/cirurgia , Disparidades em Assistência à Saúde/economia , Cobertura do Seguro/normas , Seguro Saúde/normas , Cirurgia de Readequação Sexual/economia , Adulto , Fatores Etários , Estudos Transversais , Feminino , Disforia de Gênero/diagnóstico , Disforia de Gênero/economia , Genitália/cirurgia , Guias como Assunto/normas , Acesso aos Serviços de Saúde/economia , Acesso aos Serviços de Saúde/normas , Acesso aos Serviços de Saúde/estatística & dados numéricos , Disparidades em Assistência à Saúde/normas , Disparidades em Assistência à Saúde/estatística & dados numéricos , Humanos , Cobertura do Seguro/economia , Cobertura do Seguro/estatística & dados numéricos , Seguro Saúde/economia , Masculino , Políticas , Cirurgia de Readequação Sexual/normas , Cirurgia de Readequação Sexual/estatística & dados numéricos , Padrão de Cuidado , Pessoas Transgênero
18.
Infection ; 48(2): 155-163, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32072569

RESUMO

There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days.


Assuntos
Betacoronavirus/classificação , Betacoronavirus/fisiologia , Infecções por Coronavirus/epidemiologia , Pandemias/estatística & dados numéricos , Pneumonia Viral/epidemiologia , Animais , Infecções por Coronavirus/patologia , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/transmissão , Gerenciamento Clínico , Guias como Assunto/normas , Humanos , Pandemias/prevenção & controle , Pneumonia Viral/patologia , Pneumonia Viral/prevenção & controle , Pneumonia Viral/transmissão , Organização Mundial da Saúde
19.
Forensic Sci Int ; 308: 110168, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32006879

RESUMO

Studies revising methodology are essential to the development and standardization of the field of anthropology, especially as the ultimate goal is improved forensic analyses. A series of revisions were made to the Standards for Data Collection Procedures reference manual. This includes changes made to the definitions of several standard measurements ranging from modified landmark placement to variation in the proper orientation of the caliper. The aim of this paper was to compare measurements collected using the different sets of definitions to determine if the measurements would differ significantly. Fifteen measurements were collected from 30 crania and postcrania, first using the original definitions, and then using the modified definitions and/or landmarks. The measurement differences for the 2 sets of definitions were assessed using technical error of measurement and a Kruskal-Wallis test. Results indicate that 8 of the 15 measurements differed significantly when the modified definitions were employed. Therefore, data collected using the different sets of definitions should not be used interchangeably. Forensic practitioners and laboratories making use of the updated reference manual must take into consideration how the current results might influence their standard operating procedures. Furthermore, all databases that currently make use of the original measurements, such as the South African-specific databases used in Fordisc, must be updated to include the modified measurements to stay on par with international data collection standards.


Assuntos
Pontos de Referência Anatômicos , Restos Mortais/anatomia & histologia , Pesos e Medidas Corporais/normas , Osso e Ossos/anatomia & histologia , Coleta de Dados/normas , Guias como Assunto/normas , Antropologia Forense , Humanos , Variações Dependentes do Observador
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA